Wiley Bros. Aintree Capital, LLC Insmed Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 4,933 shares of INSM stock, worth $340,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,933
Previous 4,902
0.63%
Holding current value
$340,179
Previous $357,000
4.76%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
504Shares Held
188MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$984 Million0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$894 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$876 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$491 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.34B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...